TipRanks
Advertisement
Advertisement

OPHLF Stock Latest News

ONO’s New Sjogren’s Trial Adds Quiet Upside to OPHLF’s Pipeline
Company AnnouncementsONO’s New Sjogren’s Trial Adds Quiet Upside to OPHLF’s Pipeline
4d ago
OPHLF
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
PremiumCompany Announcements
Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors
10d ago
BMY
Ono Pharma’s New Cancer Trial Adds Early-Stage Upside—and Risk—for OPHLF Investors
PremiumCompany Announcements
Ono Pharma’s New Cancer Trial Adds Early-Stage Upside—and Risk—for OPHLF Investors
25d ago
OPHLF
ONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar
PremiumCompany Announcements
ONO-6414: New First-in-Human Ulcerative Colitis Study Puts ONO Pharmaceutical on Investors’ Radar
2M ago
OPHLF
ONO Pharmaceutical Q1: Record Sales, Margin Strain
PremiumCompany Announcements
ONO Pharmaceutical Q1: Record Sales, Margin Strain
2M ago
Ono Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
PremiumCompany AnnouncementsOno Pharmaceutical Lifts Q1 Profits Despite Revenue Decline, Confirms FY2026 Outlook
2M ago
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
Premium
Company Announcements
Ono Pharma Halts Early Lymphoma Trial, Raising Fresh Questions for Investors
2M ago
OPHLF
OPHLF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
OPHLF Upcoming Earnings Report: What to Expect?
2M ago
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
PremiumCompany Announcements
Ono’s New GIST Study Puts Early‑Stage Oncology Back in Focus for OPHLF Investors
2M ago
OPHLF
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
PremiumCompany Announcements
Ono Pharma’s ONO-1110 Pain Trial Reaches Completion, Setting Up a Key Readout
2M ago
OPHLF
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
PremiumCompany Announcements
ONO-1110 Depression Trial Completion: What It Means for OPHLF Investors
2M ago
OPHLF
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
PremiumCompany Announcements
ONO’s ONO‑1110 Trial Completion Puts Social Anxiety Bet in Investor Focus
2M ago
OPHLF
ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
PremiumCompany AnnouncementsONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors
3M ago
OPHLF
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
Premium
Company Announcements
Real-World Data on Nivolumab Plus Chemo in Japanese Gastric Cancer: What Investors Should Watch
3M ago
BMY
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
Premium
Company Announcements
Ono’s ONO-4578 Breast Cancer Combo Clears Phase I Milestone, Setting Up the Next Investor Catalyst
4M ago
OPHLF
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
PremiumCompany Announcements
ONO’s ONO-7018 Trial Termination: What It Means for OPHLF Investors
4M ago
OPHLF
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
PremiumCompany Announcements
Ono’s Real-World Tirabrutinib Study in Taiwan Reaches Completion, Setting Up a New Catalyst for OPHLF
4M ago
OPHLF
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
PremiumCompany Announcements
Ono’s Phase 3 Sapablursen Trial Targets Polycythemia Vera Upside for OPHLF Investors
5M ago
OPHLF
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
PremiumCompany Announcements
ONO Pharmaceutical Details FY2025 Results and FY2026 Outlook with Focus on Pipeline and Core Metrics
5M ago
Ono Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
PremiumCompany AnnouncementsOno Pharmaceutical Delivers Strong FY 2025 Profits but Guides for Lower Revenue in FY 2026
5M ago
Is OPHLF a Buy, Before Earnings?
Premium
Pre-Earnings
Is OPHLF a Buy, Before Earnings?
5M ago
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
Premium
Company Announcements
ONO Pharmaceutical Nears Key Readout in Lung Cancer Combo Trial With Tagrisso
6M ago
OPHLF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >